NeuroOne CEO Dave Rosa talks uplisting on Nasdaq, upcoming advancements By: Minneapolis / St. Paul Business Journal via Business Journals December 14, 2021 at 16:38 PM EST NeuroOne commercialized its first diagnostic brain-scan product in January and uplisted to the Nasdaq in May. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
